Evidence map›Paper›PMID 24328084›Full record

ArticleJournal of proteome research2014

Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.

Xue Shi, Xiaoli Wei, Imhoi Koo, Robin H Schmidt, Xinmin Yin, Seong Ho Kim, Andrew Vaughn, Craig J McClain, Gavin E Arteel, Xiang Zhang and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 67 citations in OpenAlex.

  1. Mechanisms of Metal-Induced Hepatic Inflammation.Current environmental health reports · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Mechanisms of Environmental Contributions to Fatty Liver Disease.Current environmental health reports · 2019
    Review
  11. Article
  12. Simultaneous Quantification of Nucleosides and Nucleotides from Biological Samples.Journal of the American Society for Mass Spectrometry · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Xue ShiDepartment of Chemistry, University of Louisville, Louisville, KY 40292.
Xiaoli WeiDepartment of Chemistry, University of Louisville, Louisville, KY 40292.
Imhoi KooDepartment of Chemistry, University of Louisville, Louisville, KY 40292.
Robin H SchmidtDepartment of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40292.
Xinmin YinDepartment of Chemistry, University of Louisville, Louisville, KY 40292.
Seong Ho KimBiostatistics Core, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201.
Andrew VaughnDepartment of Medicine, University of Louisville, Louisville, KY 40292.
Craig J McClainDepartment of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40292.
Gavin E ArteelDepartment of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40292.
Xiang Zhang *Department of Chemistry, University of Louisville, Louisville, KY 40292.
Walter H Watson *Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40292.
University of Louisville · USUniversity of Louisville Hospital · USLouisville VA Medical Center · USThe Barbara Ann Karmanos Cancer Institute · US

Funding

UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Lipotoxicity in Alcoholic Liver DiseaseR01AA018844 · NIAAA · UNIVERSITY OF NORTH CAROLINA GREENSBORO · PI ZHANXIANG ZHOU · 2009 to 2026
$6.0M
Tumor Necrosis Factor and Alcoholic Liver DiseaseR37AA010762 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2001 to 2010
$3.6M
S-adenosylhomocysteine and S-adenosylmethionine in Alcoholic Liver DiseaseR01AA015970 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2005 to 2010
$2.0M
The Role of Alcohol in HIV Therapy HepatotoxicityR01AA018016 · NIAAA · UNIVERSITY OF LOUISVILLE · PI BARVE, SHIRISH S, EATON, JOHN W · 2008 to 2012
$1.7M
Cyclic AMP, Cytokine Modulation and Alcoholic Liver DiseaseR01AA018869 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2009 to 2013
$1.7M
Biomarkers for SteatohepatitisRC2AA019385 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2009 to 2010
$1.6M
Novel therapies in alcoholic hepatitis University of LouisvilleU01AA021901 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2012 to 2017
$1.5M
Mechanisms of S-adenosylmethionine in NASHR01DK071765 · NIDDK · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2005 to 2009
$1.5M
Mass Informatics of Two Dimensinoal Gas Chromatography Time-of-flight Mass SpectrR01GM087735 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ZHANG, XIANG · 2009 to 2012
$1.4M
Alcohol Liver Disease and Alcohol-Nutrient InteractionsP01AA017103 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2008 to 2010
$1.3M
University of Louisville Bioinformatics Faculty Recruitment for EpigeneticsP30AA019360 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2009 to 2010
$811k
NIAAA NIH HHS 1RC2AA019385NIAAA NIH HHS P01 AA017103NIAAA NIH HHS P01AA017103NIAAA NIH HHS P30 AA019360NIAAA NIH HHS P30AA019360NIAAA NIH HHS R01 AA015970NIAAA NIH HHS R01AA015970NIAAA NIH HHS R01 AA018016NIAAA NIH HHS R01AA018016NIAAA NIH HHS R01 AA018844NIAAA NIH HHS R01AA018844NIAAA NIH HHS R01 AA018869NIAAA NIH HHS R01AA018869NIAAA NIH HHS R37 AA010762NIAAA NIH HHS R37AA010762NIAAA NIH HHS RC2 AA019385NIAAA NIH HHS U01 AA021901NIDDK NIH HHS R01 DK071765NIDDK NIH HHS R01DK071765NIEHS NIH HHS R21 ES021311NIEHS NIH HHS R21ES021311NIEHS NIH HHS T32 ES011564NIGMS NIH HHS R01 GM087735NIGMS NIH HHS R01GM087735
6 · The paper itself

Abstract

Arsenic is a widely distributed environmental component that is associated with a variety of cancer and non-cancer adverse health effects. Additional lifestyle factors, such as diet, contribute to the manifestation of disease. Recently, arsenic was found to increase inflammation and liver injury in a dietary model of fatty liver disease. The purpose of the present study was to investigate potential mechanisms of this diet-environment interaction via a high-throughput metabolomics approach. GC×GC-TOF MS was used to identify metabolites that were significantly increased or decreased in the livers of mice fed a Western diet (a diet high in fat and cholesterol) and co-exposed to arsenic-contaminated drinking water. The results showed that there are distinct hepatic metabolomic profiles associated with eating a high fat diet, drinking arsenic-contaminated water, and the combination of the two. Among the metabolites that were decreased when arsenic exposure was combined with a high fat diet were short-chain and medium-chain fatty acid metabolites and the anti-inflammatory amino acid, glycine. These results are consistent with the observed increase in inflammation and cell death in the livers of these mice and point to potentially novel mechanisms by which these metabolic pathways could be altered by arsenic in the context of diet-induced fatty liver disease.

Indexed as

Diet, High-FatDisease Models, AnimalMetabolomicsAnimalsArsenicChromatography, GasFatty LiverMaleMass SpectrometryMiceMice, Inbred C57BLArsenic

Identifiers

PMID24328084
PMCPMC3946282
OpenAlexW2038634709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.